StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.95−0.02 (-2.05%)

Close on Nov 20, 2026Market cap $18.30MP/E –Yield –

Cocrystal Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cocrystal Pharma's revenue for the twelve months ending Dec 31, 2020 was $2.01M, down 69.3% year over year. For fiscal 2020 it was $2.01M, down 69.3% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2020Dec 31, 2020$2.01M-69.3%
FY2019Dec 31, 2019$6.56M-48.4%
FY2011Dec 31, 2011$12.71M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$105.00K-81.0%
Q1 FY2026Mar 31, 2026$225.00K-51.2%
Q4 FY2020Dec 31, 2020$510.00K+26.9%
Q3 FY2020Sep 30, 2020$489.00K-0.6%
Q2 FY2020Jun 30, 2020$554.00K-6.4%
Q1 FY2020Mar 31, 2020$461.00K-90.9%
Q4 FY2019Dec 31, 2019$402.00K–
Q3 FY2019Sep 30, 2019$492.00K–
Q2 FY2019Jun 30, 2019$592.00K–
Q1 FY2019Mar 31, 2019$5.08M–

More Cocrystal Pharma figures

See a number that looks wrong?